Operating within the pharmaceutical domain, Shukra Pharmaceuticals Limited has firmly established its presence. The company embarked on its journey with a fully integrated plant situated in Rakanpor, Kalol, Gandhinagar – Gujarat. Since its inception, Shukra Pharmaceuticals has achieved remarkable strides in terms of operations and has achieved substantial expansion. Presently, they operate an internationally accredited Laboratory in Ahmedabad, dedicated to upholding the highest quality standards for every product.
Shukra Pharmaceuticals is actively engaged in various operations, including:
- Contract Manufacturing
- Loan License
- Domestic and International Operations
The company’s dedicated team, comprising research analysts, medical officers, and technical experts, remains unwavering in their commitment to ensuring the quality of each product. They adhere rigorously to regulations, thereby delivering products of exceptional quality and reliability.
Shukra Pharmaceuticals Ltd Stock Quote #
- Open: ₹134.00
- High – Low: ₹134.20 – ₹124.00
- Previous Close: ₹127.85
- Total Traded Value: 1,324
- 52 Weeks High: ₹111.52 (May 04, 2023)
- 52 Weeks Low: ₹0.45 (Jan 30, 2003)
- Updated On: Aug 11, 2023 4:00 PM
Shukra Pharmaceuticals Rights Issue 2023 Detail #
| Issue Open | Feb 15, 2023 – Feb 28, 2023 |
| Security Name | Shukra Pharmaceuticals Limited |
| Issue Size (Shares) | 9,394,050 |
| Issue Size (Amount) | ₹18.79 Crores |
| Issue Price | ₹20 per share |
| Face Value | ₹10 per share |
| Listing At | BSE |
| Terms of Payment | Rs. 5 per Rights Equity Share to be paid on Application and balance to be paid in three calls as determined. |
| Entitlement | 6 Equity Shares for every 1 Fully Paid Equity Share held |
Shukra Pharmaceuticals Rights Issue 2023 Issue Timetable #
| Record Date | Feb 2, 2023 |
| Credit of Rights Entitlements | Feb 13, 2023 |
| Bid/Offer Opens On | Feb 15, 2023 |
| Renunciation of Rights Entitlements | Feb 23, 2023 |
| Bid/Offer Closes On | Feb 28, 2023 |
| Deemed Date of Allotment | Mar 8, 2023 |
| Credit Date | Mar 14, 2023 |
| Listing Date | Mar 15, 2023 |
Company Financials #
| Period Ended | Total Assets | Total Revenue | Profit After Tax | Net Worth |
|---|---|---|---|---|
| 31-Mar-21 | 35.61 | 11.55 | 0.19 | 15.60 |
| 31-Mar-22 | 35.11 | 20.57 | 0.75 | 16.35 |
| Amount in ₹ Crore | ||||
Objects of the Issue: #
The Company proposes to utilize the Net Proceeds to:
- To augment the existing and incremental working capital requirement of the company; and
- General Corporate Purposes
Shukra Pharmaceuticals Rights Issue 2023 Documents #
Company Contact Information #
Veer House, 3rd Floor, Judges Bungalow Road,
Opp. WIAA Motor Training School,
Bodakdev, Ahmedabad- 380054Phone: +91 79 48901030
Email: info@shukrapharmaceuticals.com
Website: http://www.shukrapharmaceuticals.com/#
Shukra Pharmaceuticals Rights Issue 2023 Registrar #
- Purva Sharegistry India Pvt Ltd
Phone: +91-022-23018261/ 23016761
Email: support@purvashare.com
Website: https://www.purvashare.com/queries/
Shukra Pharmaceuticals Rights Issue 2023 Lead Manager(s) #
